This article is a correction to:
Research advances in drug therapy of endometriosis
Jianyou Shi1,2†
Xin Tan1,2†Guimei Feng3,4†
Yuan Zhuo5Zhongliang Jiang6
Srikanth Banda7Lin Wang8Wei Zheng5
Lu Chen1,2*
Dongke Yu1,2*
Chun Guo3,4*- 1Department of Pharmacy, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
- 2Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
- 3Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- 4Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China
- 5Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 6Miller School of Medicine, University of Miami, Miami, FL, United States
- 7Department of Chemistry and Biochemisty, Florida International University, Miami, FL, United States
- 8College of Food and Bioengineering, Xihua University, Chengdu, China
A Corrigendum on
Research advances in drug therapy of endometriosis
by Shi J, Tan X, Feng G, Zhuo Y, Jiang Z, Banda S, Wang L, Zheng W, Chen L, Yu D and Guo C (2023). Front. Pharmacol. 14:1199010. doi: 10.3389/fphar.2023.1199010
In the published article, there was an error in affiliation 3. Instead of “Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu 610072, China”, it should be “Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China”. There was also an error in affiliation 4. Instead of “Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China”, it should be “Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: endometriosis, pathogenesis, medical treatment, gonadotropin-releasing antagonist, aromatase inhibitor
Citation: Shi J, Tan X, Feng G, Zhuo Y, Jiang Z, Banda S, Wang L, Zheng W, Chen L, Yu D and Guo C (2023) Corrigendum: Research advances in drug therapy of endometriosis. Front. Pharmacol. 14:1254518. doi: 10.3389/fphar.2023.1254518
Received: 07 July 2023; Accepted: 10 July 2023;
Published: 14 July 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Shi, Tan, Feng, Zhuo, Jiang, Banda, Wang, Zheng, Chen, Yu and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lu Chen, 50796877@qq.com; Dongke Yu, yudongke@med.uestc.edu.cn; Chun Guo, chunguo11@hotmail.com
†These authors have contributed equally to this work and share first authorship